-
KeyBanc Reiterates Sector Weight Rating on Standard BioTools Inc (LAB)
-
Labranche (LAB) Tops Q2 EPS by 2c ; Offers Guidance
-
Standard BioTools wins contract for Singapore's 100,000-sample study
-
Illumina (ILMN) to acquire SomaLogic
-
Standard BioTools (LAB) Sells SomaLogic to Illumina (ILMN)
-
Labranche (LAB) Misses Q1 EPS by 1c ; Offers Guidance
-
Sight Sciences (SGHT) appoints Gary Burbach to Board
-
KeyBanc Downgrades Standard BioTools Inc (LAB) to Sector Weight
-
Labranche (LAB) Misses Q4 EPS by 2c ; Offers Guidance
-
TD Cowen: 'Assessing Impact of US Ban on China Exports for LCMS & Flow Cyt Instruments'
-
Standard BioTools (LAB) Announces Preliminary Fourth Quarter and Full Year 2024 Revenue
-
Standard BioTools (LAB) Appoints Alex Kim as CFO
-
Standard BioTools Inc (LAB) PT Lowered to $2.50 at TD Cowen
-
Labranche (LAB) Tops Q3 EPS by 2c, provides guidance
-
TD Cowen Reiterates Buy Rating on Standard BioTools Inc (LAB)
-
Labranche (LAB) Misses Q2 EPS by 4c
-
Standard BioTools (LAB) Announces CFO Resignation
-
Standard BioTools (LAB) Files for 105.12M Share Offering by Selling Stockholders

